Results 1 to 10 of about 1,424,424 (268)

Acknowledgment to the Reviewers of Current Oncology in 2022

open access: yesCurrent Oncology, 2023
High-quality academic publishing is built on rigorous peer review [...]
Current Oncology Editorial Office
doaj   +1 more source

Acknowledgment to Reviewers of Current Oncology in 2021

open access: yesCurrent Oncology, 2022
Rigorous peer-reviews are the basis of high-quality academic publishing [...]
Current Oncology Editorial Office
doaj   +1 more source

Expert consensus on early diagnosis and treatment of bladder cancer (2024 edition) [PDF]

open access: yesZhongguo aizheng zazhi
Bladder cancer is one of the common cancers of urinary system, which seriously threatens the life and health of Chinese population. In recent years, with the extension of life expectancy and the acceleration of aging, the incidence and mortality rates of
Oncology Group Urologic Chinese
doaj   +2 more sources

Expert Consensus on Management of Common Gynecological Malignancies Combining General Practice and Specialist [PDF]

open access: yesZhongguo quanke yixue
To enhance the overall health management for patients with gynecologic malignant tumors, and to fully leverage the role of primary healthcare institutions in screening and rehabilitation, the Gynecological Oncology Group of the Oncology Department of ...
Gynecological Oncology Group of the Oncology Department of Capital Medical University
doaj   +1 more source

Clinical Practice Guidelines for Immune Checkpoint Inhibitor Therapy in Gynecological Tumors

open access: yesXiehe Yixue Zazhi, 2021
Immune checkpoint inhibitors (ICI) have shown efficacy for some patients with gynecological tumors, which are mainly used to treat persistent, recurrent, or metastatic patients.
Gynecological Oncology Society of Chinese Medical Association
doaj   +1 more source

Post-Marketing Surveillance of a generic Oxaliplatin (AlvoxalⓇ) in Iranian Patients with Cancer

open access: yesCurrent Therapeutic Research, 2022
: Background: CRC is the second and third most common cancer in women and men, respectively. The national comprehensive cancer network guidelines recommend oxaliplatin-based chemotherapy as a preferred regimen for patients with advanced or metastatic ...
Farhad Shahi   +16 more
doaj   +1 more source

Survival Analysis and Correlates with Molecular Epidemiology: 10-year Retrospective Series of High-Grade Glioma in Pakistan

open access: yesJournal of Cancer and Allied Specialties, 2023
Introduction: High-grade gliomas are malignant, recurring primary CNS tumors requiring extensive postoperative chemotherapy and radiation treatment. Isocitrate dehydrogenase (IDH), 1p19q, and ATRX mutations significantly influence survival and response ...
Mashal Shah   +3 more
doaj   +1 more source

Rubidium Uptake in Chest Tumors on PET/CT

open access: yesWorld Journal of Nuclear Medicine, 2022
Background Chest tumors are often found incidentally on cardiac scans; we aimed to describe the findings of rubidium (Rb) in incidentally discovered extracardiac tumors.
Jorge D. Oldan   +3 more
doaj   +1 more source

Frailty as a Predictor of Complications and Transplant-Free Survival after Transarterial Chemoembolization of Hepatocellular Carcinoma

open access: yesJournal of Clinical Interventional Radiology ISVIR, 2023
Purpose To determine the association between frailty, 30-day complications, rehospitalization, and transplant-free survival (TFS) following conventional and drug-eluting bead transarterial chemoembolization.
Rana Rabei   +6 more
doaj   +1 more source

Oncologic Outcomes of a Novel Mapping Biopsy Technique Before Surgical Excision in the Management of Extramammary Paget Disease

open access: yesSociété Internationale d’Urologie Journal, 2023
ObjectiveTo analyze oncologic outcomes of patients with extramammary Paget disease (EMPD) undergoing a novel mapping biopsy before tumor excision (WLE). MethodsWe analyzed 19 consecutive patients with EMPD treated with biopsy and/or surgical excision at
Kyle M. Rose   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy